SC Condemns Witch-Hunting, Says Superstition Continues to Override Constitutional Morality || SC: Retired Judges Appointed to Central Industrial Tribunals Not Entitled to Pay Parity || SC: Electricity Boards Liable for Electrocution Deaths under Strict, Not Absolute Liability || Supreme Court Criticizes Courts For Conducting ‘Mini-Trials’ in Temporary Injunction Matters || SC: Common Judgment in Suits by Same Plaintiff can be Challenged Through Composite Appeal || Chandigarh Court Orders Meta to Take Down AI-Generated Video of Punjab MLA Sukhpal Khaira || Delhi HC: Insolvency Professionals Must Collect & Deposit GST Even if they are Advocates || Madras HC Rejects Election Petition Challenging Colachel MLA Tharahai Cuthbert || Supreme Court: Uncrystallized Contractual Damages Not an Operational Debt under Section 9 IBC || Supreme Court: Interest Accrued in Suspense Account After NPA Classification is Recoverable as Debt

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :